1-2 of 2
Sarah Kaster, BS
Close
Sort by
Journal Articles

An Open-Label Phase I Study of the Safety and Efficacy of RAD001 in Combination with Lenalidomide in the Treatment of Patients with Relapsed and Relapsed/Refractory Multiple Myeloma.

Noopur Raje, MD., Paul Richardson, M.D., Parameswaran N Hari, MD, Anuj Mahindra, Sarah Kaster, BS, Christine Connolly, Linda Rivera, Gaurav Chetri, Sarah Dean, Paulette Jacobs, Ayman Saad, MD, Jacob Laubach, Irene M. Ghobrial, M.D., Robert L Schlossman, M.D., Ph.D., Jennifer Adams, Wendy Makrides, Edie Weller, PhD, Nikhil Munshi, M.D., Kenneth C. Anderson, MD
Journal: Blood
Blood (2009) 114 (22): 3856.
https://doi.org/10.1182/blood.V114.22.3856.3856
Published: 2009
Journal Articles

Lenalidomide, Bortezomib, and Dexamethasone in Patients with Newly Diagnosed Multiple Myeloma: Encouraging Efficacy in High Risk Groups with Updated Results of a Phase I/II Study

Paul Richardson, MD, Sagar Lonial, MD, Andrzej Jakubowiak, MD, PhD, Sundar Jagannath, MD, Noopur S Raje, MD, David Avigan, MD, Irene M Ghobrial, MD, Robert L Schlossman, MD, Amitabha Mazumder, MD, Nikhil C Munshi, MD, David H Vesole, MD, PhD, Robin Joyce, MD, Deborah Doss, RN, OCN, Diane L Warren, BS, Stephen W Hayes, Sarah Kaster, BS, Carol Delaney, BSN, Marisa Lauria, BA, Constantine Mitsiades, MD, PhD, Teru Hideshima, MD, PhD, Robert D. Knight, MD, Dixie-Lee Esseltine, MD, Kenneth C Anderson, MD
Journal: Blood
Blood (2008) 112 (11): 92.
https://doi.org/10.1182/blood.V112.11.92.92
Published: 2008